Skip To Main Content
Daniel Zips on Muck Rack

Daniel Zips

As seen in: JAMA Network, European Urology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Daniel Zips’s profile

Articles by Daniel Zips

Organ Preservation and Quality of Life After Total Neoadjuvant Treatment in Rectal Cancer

|
By Markus Diefenhardt, Emmanouil Fokas, Rebekka Kosmala, Bülent Polat, Anke Schlenska-Lange, Thomas Kuhnt, Michael Ghadimi, Stefan Rieken, Armin Wiegering, Matthias Schwarzbach, Maximilian Fleischmann, Robert Grützmann, Oliver J Ott, Peter Martus, Alfred Konigsrainer, Daniel Zips, Ralf-Dieter Hofheinz, Cihan Gani, Claus Rödel, Christoph Thomas Germer
| JAMA Network Verified
Organ Preservation and Quality of Life After Total Neoadjuvant Treatment in Rectal Cancer Supplement 1. eTable 1. Assigned Assessment Periods for Quality-of-Life Questionnaires eTable 2. QOL Measurements for the EORTC QLQ-C30, EORTC QLQ-CR29, and Wexner Score Questionnaires at Time Points 1 to 10 for All Patients and the iNOM, pCR, and Matched Cohorts eTable 3. Results of Adjusted Longitudinal Regression Analyses in Patients With Baseline QOL Scoring eTable 4.
Open in Who Shared Issue with article?

Re: Duration of Androgen Deprivation Therapy with Postoperative Radiotherapy for Prostate Cancer: A Comparison of Long-course Versus Short-course Androgen Deprivation Therapy in the RADICALS-HD Randomised Trial

|
By Pirus Ghadjar, Daniel Zips
| European Urology Verified
Department of Radiation Oncology, Charité – Universitätsmedizin Berlin, Berlin, Germany Publication History: Accepted October 30, 2024; Published online November 12, 2024 DOI: 10.1016/j.eururo.2024.10.028Also available on ScienceDirect Copyright: © 2024 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Get full text access Log in, subscribe or purchase for full access. References 1.
Open in Who Shared Issue with article?

Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

|
By Charles Gillham, Technische Universität Dresden, Daniel Zips, Falk Pönisch
| tu-dresden.de
Background and purpose: Loco-regional failure after radiotherapy with total doses of 60-70 Gy for non-small cell lung cancer (NSCLC) remains a major clinical problem. Escalation of radiation dose is often limited because of exceeding normal tissue constraints. The present study was designed to test the hypothesis that a reduction in disease volume during radiotherapy detected by FDG PET/CT would facilitate radiation dose escalation, whilst remaining within normal tissue constraints.
Open in Who Shared Issue with article?

New anticancer agents: In vitro and in vivo evaluation

|
By Daniel Zips, Howard Thames, Michael Baumann Verified
| tu-dresden.de
Abstract External IDs PubMed 15796152
Open in Who Shared View Duplicates (3) Issue with article?

Impact of hypoxia and the metabolic microenvironment on radiotherapy of solid tumors: Introduction of a multiinstitutional research project

|
By Daniel Zips, Technische Universität München, Michael Flentje, Markus Adam
| tu-dresden.de
Background: Recent developments in imaging technology and tumor biology have led to new techniques to detect hypoxia and related alterations of the metabolic microenvironmentin tumors. However, whether these new methods can predict radiobiological hypoxia and outcome after fractionated radiotherapy still awaits experimental evaluation.
Open in Who Shared Issue with article?

Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas

|
By Daniel Zips, Ala Yaromina, Katja Le, Annegret Dörfler
| tu-dresden.de
Abstract Externe IDs PubMed 19409639 Schlagworte Angiogenesis, Angiogenic receptor tyrosine kinases, Fractionated radiotherapy, Local tumour control, Radiobiological hypoxia, Tumour microenvironment
Open in Who Shared Issue with article?

Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts

|
By Ala Yaromina, Johannes Gutenberg-Universität Mainz, Daniel Zips, Verena Quennet
| tu-dresden.de
Purpose:To examine relationships between tumour hypoxia, perfusion and metabolic microenvironment at the microregional level in three different human squamous cell carcinomas (hSCC). Materials and methods:Nude mice bearing FaDu, UT-SCC-15, and UT-SCC-5 hSCC were injected with pimonidazole hypoxia and Hoechst perfusion markers. Bioluminescence imaging was used to determine spatial distribution of glucose and lactate content in serial tumour sections.
Open in Who Shared Issue with article?

Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy

|
By Mechthild Krause, Daniel Zips, Howard Thames, Johann Kummermehr
| tu-dresden.de
Abstract Externe IDs PubMed 16916560 Schlagworte
Open in Who Shared Issue with article?

Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition

|
By Peter Geyer, Daniel Zips, Wolfgang Eicheler, Franziska Hessel
| tu-dresden.de
Abstract External IDs PubMed 15958586
Open in Who Shared Issue with article?
Show More